Macular edema is the accumulation of fluid in the macular retina or under the retina. Macular edema is an important cause of vision loss.Diabetic macular edema is a common ocular complication of diabetes.It causes blood vessels in the retina at the back of the eye to leak, causing swelling.
This report contains market size and forecasts of Cystoid Edema Clinical Trials in Global, including the following market information:
Global Cystoid Edema Clinical Trials Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cystoid Edema Clinical Trials market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Traction Diabetes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cystoid Edema Clinical Trials include Allergan, Roche, Bayer AG, Regeneron, Novartis, Merck, AstraZeneca and Bluefish Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cystoid Edema Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cystoid Edema Clinical Trials Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cystoid Edema Clinical Trials Market Segment Percentages, by Type, 2021 (%)
Traction Diabetes
Diabetic Retinopathy
Cystic
Global Cystoid Edema Clinical Trials Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cystoid Edema Clinical Trials Market Segment Percentages, by Application, 2021 (%)
Hospital
Medical Research Organization
Other
Global Cystoid Edema Clinical Trials Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cystoid Edema Clinical Trials Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cystoid Edema Clinical Trials revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cystoid Edema Clinical Trials revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Roche
Bayer AG
Regeneron
Novartis
Merck
AstraZeneca
Bluefish Group